Skip to search.
 FTSE 100 Up 0.05%

AbbVie Inc. (ABBV)

-NYSE
66.23 Up 1.51(2.33%) 29 Jul 21:00
|After Hours: : 66.12 Down 0.11 (0.17%) 30 Jul 00:58
Prev Close:64.72
Open:65.27
Bid:66.10 x 400
Ask:66.35 x 100
1y Target Est:70.17
Beta:1.46162
Next Earnings Date:N/A
Day's Range:65.15 - 66.40
52wk Range:45.45 - 70.79
Volume:10,525,016
Avg Vol (3m):9,048,750
Market Cap:111.27b
P/E (ttm):19.91
EPS (ttm):3.33
Div & Yield:2.28 (3.51%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ABBVUp 2.33%111.27b
PFEUp 0.60%223.73b
MRKUp 0.39%162.37b

Key Statistics

Forward P/E (1 yr):11.76
P/S (ttm):4.40
Ex-Dividend Date:13-Jul-16

Analysts

Annual EPS Est (Dec-16) :4.77
Quarterly EPS Est (Sep-16) :1.19
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):0.86

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; IMBRUVICA an oral therapy for the trea... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback